AstraZeneca Pharma India surges 19% to fresh record high
** Shares of AstraZeneca Pharma India ASTR.NS rise as
much as 19.2% to 6,737.70 rupees, extending record high rally;
closes up 17.5%
** About 342,000 shares change hands, 8x 30-day avg
** The reason for the stock move was not immediately clear
** Stock has gained more than 46% after the company on Dec
21 announced that it would launch a breast cancer drug, Enhertu,
this month
** ASTR rose 67% in 2023 vs 33.6% gains in pharma index
.NIPHARM
(Reporting by Sethuraman NR in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan